IR@PKUHSC  > 北京大学第一临床医学院  > 肾脏内科
学科主题肾脏病学
药用活性炭有效降低顽固性高磷血症透析患者血磷水平与钙磷乘积
其他题名Oral activated charcoal decreases serum phosphate level and calcium phosphorus products in dialysis patients with refractory hyperphosphataemia
程叙扬; 甘红兵; 吕继成; 王芳; 左力
关键词 透析 高磷血症 Charcoal Dialysis Hyperphosphataemia
刊名中华肾脏病杂志
2012
DOI10.3760/cma.j.issn.1001-7097.2012.01.005
28期:1页:21-24
收录类别中国科技核心期刊 ; 中文核心期刊 ; CSCD
文章类型Journal Article
摘要目的 研究口服药用活性炭对未能控制的高磷血症透析患者血磷与钙磷乘积的作用.方法 采用单中心、前瞻性、自身前后对照研究.经含钙的磷结合剂治疗后仍存在高磷血症的血液透析或腹膜透析患者,餐中加服药用活性炭4.5~7.2 g/d治疗3个月.检测治疗前后血磷、钙、钙磷乘积、全段甲状旁腺激素( iPTH)、白蛋白、血红蛋白水平.用配对t检验进行统计学分析.结果 与治疗前比较,治疗3个月后患者血磷水平显著下降[(1.85±0.30)mmol/L比(2.16±0.34) mmol/L,P<0.01];血钙磷乘积也相应显著下降[(54.12±8.37) mg2/dl2比(63.93±8.83) mg2/dl2,P<0.01];有更多并发继发性甲状旁腺功能亢进症的患者可以接受维生素D治疗(83.3%比50%);血钙与iPTH水平无显著性变化(P=0.734,0.665).活性碳治疗期间血白蛋白水平较前下降[(40.1±2.2)g/L比(41.7±2.9) g/L,P=0.001].结论 顽固性高磷血症透析患者在继续原有磷结合剂治疗基础上,口服药用活性炭可以有效地降低血磷水平与钙磷乘积,对血钙及iPTH水平没有显著性影响.活性炭治疗可使患者血白蛋白水平轻度下降. Objective To study the effect of medically activated charcoal on serum phosphorus level and calcium-phosphorus products in dialysis patients with poorly controlled hyperphosphatemia. Methods A single-center,prospective,self-controlled study was performed.Medically activated charcoal was administered 4.5-7.2 g per day with meals for three months to hemodialysis or peritoneal dialysis patients with hyperphosphatemia after taking calcium-based phosphate binders.The levels of blood phosphorus,calcium,calcium-phosphorus products,intact parathyroid hormone (iPTH),albumin and hemoglobin were detected before and after the treatment.The results were analyzed using paired t-test. Results After 3 months of treatment,the patients' serum phosphorus level was significantly reduced from (2.16 ±0.34) mmol/L (pretreatment) to (1.85±0.30) mmol/L (post-treatment) (P<0.01).Similarly,the serum calciumphosphorus products were lowered from pre-treatment level of (63.93 ±8.83) mg2/dl2 to posttreatment of (54.12±8.37) mg2/dl2 (P<0.01).Serum albumin level was slightly reduced from (41.7±2.9) g/L to (40.1±2.2) g/L (P=0.001).In contrast,there were no significant changes in serum calcium and iPTH levels when compared pre- to post-treatment values (P=0.734 and P=0.665,repectively). Conclusion In combination with calcium-based phosphate binder therapy,oral medically activated charcoal can effectively reduce the levels of blood phosphorus and calciumphosphorus products in dialysis patients with refractory hyperphosphatemia.
语种中文
原文出处查看原文
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/45791
专题北京大学第一临床医学院_肾脏内科
作者单位100034,北京大学第一医院肾内科北京大学肾脏疾病研究所卫生部肾脏病重点实验室
推荐引用方式
GB/T 7714
程叙扬,甘红兵,吕继成,等. 药用活性炭有效降低顽固性高磷血症透析患者血磷水平与钙磷乘积[J]. 中华肾脏病杂志,2012,28(1):21-24.
APA 程叙扬,甘红兵,吕继成,王芳,&左力.(2012).药用活性炭有效降低顽固性高磷血症透析患者血磷水平与钙磷乘积.中华肾脏病杂志,28(1),21-24.
MLA 程叙扬,et al."药用活性炭有效降低顽固性高磷血症透析患者血磷水平与钙磷乘积".中华肾脏病杂志 28.1(2012):21-24.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[程叙扬]的文章
[甘红兵]的文章
[吕继成]的文章
百度学术
百度学术中相似的文章
[程叙扬]的文章
[甘红兵]的文章
[吕继成]的文章
必应学术
必应学术中相似的文章
[程叙扬]的文章
[甘红兵]的文章
[吕继成]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。